Celecoxib activates a novel mitochondrial apoptosis signaling pathway.

The FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Volumn 17, Issue 11, 2003, Pages 1547-1549

  Jendrossek, Verena ^a   Handrick, René ^a   Belka, Claus ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APAF1 PROTEIN, HUMAN; APAF1 PROTEIN, MOUSE; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASP9 PROTEIN, HUMAN; CASP9 PROTEIN, MOUSE; CASPASE; CASPASE 9; CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ISOENZYME; MEMBRANE PROTEIN; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN; PROTEIN BCL 2; PTGS2 PROTEIN, HUMAN; PYRAZOLE DERIVATIVE; SULFONAMIDE; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; CELL CULTURE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; KINETICS; LEUKEMIA CELL LINE; METABOLISM; MITOCHONDRION; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION; ULTRASTRUCTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; CASPASE 9; CASPASES; CELLS, CULTURED; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; ISOENZYMES; JURKAT CELLS; KINETICS; MEMBRANE PROTEINS; MICE; MITOCHONDRIA; MODELS, BIOLOGICAL; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; PYRAZOLES; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; SULFONAMIDES; TUMOR CELLS, CULTURED;

MLCS; MLOWN;

EID: 0041703017     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.02-0947fje     Document Type: Article

References (0)